![Cedric Ragsdale](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cedric Ragsdale
Private Equity Investor bei
HealthEdge Investment Partners, LLC
Profil
Cedric Ragsdale currently works at HealthEdge Investment Partners, LLC, as Operating Partner.
Mr. Ragsdale also formerly worked at Lilly del Caribe, Inc., as Treasurer & Finance Director from 2002 to 2006, BioTissue Holdings, Inc., as Chief Financial Officer from 2010 to 2012, Stiefel Laboratories, Inc., as Vice President-Finance from 2006 to 2010, Advanced Bio-Technologies, Inc., as CFO, Enaltus LLC, as Chief Financial Officer, and Bijoux Nouveau, Inc., as Chief Financial Officer from 2012 to 2013.
Mr. Ragsdale received his Masters Business Admin degree in 1992 from Clark Atlanta University and undergraduate degree in 1990 from Kettering University.
Aktive Positionen von Cedric Ragsdale
| Unternehmen | Position | Beginn |
|---|---|---|
HealthEdge Investment Partners, LLC
 HealthEdge Investment Partners, LLC Investment ManagersFinance HealthEdge Investment Partners invests in both public and private lower middle market companies located in the United States with an EBITDA of USD 2 - 15 million and revenues of USD 5 - 75 million. The firm target companies operating in the field of the healthcare sector. It provides financing for buyouts, recapitalizations and growth capital requirements. It also makes majority and significant minority control investments in companies. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Cedric Ragsdale
| Unternehmen | Position | Ende |
|---|---|---|
Bijoux Nouveau, Inc.
 Bijoux Nouveau, Inc. Apparel/Footwear RetailRetail Trade Engages in the wholesale and retail of apparel and fashion products | Finanzdirektor/CFO | 30.06.2013 |
BioTissue Holdings, Inc.
 BioTissue Holdings, Inc. BiotechnologyHealth Technology Develops, manufactures and commercialization regenerative amniotic tissue-based products | Finanzdirektor/CFO | 31.12.2012 |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Finanzdirektor/CFO | 31.12.2010 |
Lilly del Caribe, Inc.
 Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Finanzdirektor/CFO | 31.12.2006 |
Advanced Bio-Technologies, Inc.
 Advanced Bio-Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops dermatological products | Finanzdirektor/CFO | - |
Ausbildung von Cedric Ragsdale
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
BioTissue Holdings, Inc.
BioTissue Holdings, Inc. BiotechnologyHealth Technology Develops, manufactures and commercialization regenerative amniotic tissue-based products | Health Technology |
Clark Atlanta University
 Clark Atlanta University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kettering University
 Kettering University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Advanced Bio-Technologies, Inc.
Advanced Bio-Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops dermatological products | Health Technology |
HealthEdge Investment Partners, LLC
HealthEdge Investment Partners, LLC Investment ManagersFinance HealthEdge Investment Partners invests in both public and private lower middle market companies located in the United States with an EBITDA of USD 2 - 15 million and revenues of USD 5 - 75 million. The firm target companies operating in the field of the healthcare sector. It provides financing for buyouts, recapitalizations and growth capital requirements. It also makes majority and significant minority control investments in companies. | Finance |
Enaltus LLC
 Enaltus LLC Household/Personal CareConsumer Non-Durables Develops, markets and sells skincare products | Consumer Non-Durables |
Bijoux Nouveau, Inc.
Bijoux Nouveau, Inc. Apparel/Footwear RetailRetail Trade Engages in the wholesale and retail of apparel and fashion products | Retail Trade |
